Ficolin-3 has been associated with metabolic diseases including gestational, prediabetes, and type 2 diabetes (139, 140), and identified as biomarkers in axial spondyloarthritis (141) and as a prognostic biomarker for esophageal cancer (142). The gene discussed is FCN3; the disease is type 2 diabetes mellitus.